What is AlloHome?

AlloHome™ is a remote patient monitoring (RPM) solution designed to drive patient engagement and timely interventions for patients pre- and post-transplant.

With AlloHome, patients receive Bluetooth-enabled devices to capture vital sign readings in their own homes. These devices automatically pair to deliver real-time data to trained professionals who monitor and track readings.

Regular monitoring of critical patient data improves continuity of care, enhances telehealth visits, and enables chronic care management of patients along the transplant journey.

AlloHome has the potential to reduce readmission rates after transplant surgery and improve short- and long-term outcomes for transplant patients.

AlloHome solution and available devices

AlloHome - AlloHome diagram icon wPatient 11 23

Remote patient monitoring

Key features:

  • Secure, web-based solution
  • No Wi-Fi or cellular data service required for patients
  • Patients prompted via text/voice/email for missing data
  • Covered by Medicare, most Medicaid and private payers
  • EMR integration available

Monitoring service benefits

  • Nurse specialists monitor, analyze, and communicate with patients to drive adherence to personalized care plans
  • Customizable patient care and escalation plans based on your program’s needs
  • Regular trend reports and automatic tracking of time-per-patient makes payer submissions easy
  • Regular at-home vitals collection enhances telehealth visits and enables more comprehensive chronic care management

How it works

Home Icon
1: Select patients to be monitored
Resources Icon
2: Develop patient-specific care plans
AlloHome - Allohome icon Smart Hub 200x200
3: Patients receive devices and training
Result Icon
4: AlloHome monitors and tracks your patients
AlloHome - icon chart no tripod
5: AlloHome provides you regular trend and billing reports
CareDx at TCT 2021 - small transparent

Who would benefit from AlloHome remote patient monitoring?

  • Any patient you are considering for transplantation including patients with heart failure, end-stage renal disease, kidney failure, interstitial lung disease, COPD, cystic fibrosis, emphysema, liver failure
  • Patients who are on transplant waitlists
  • Patients who have had a liver, heart, kidney, lung, or cellular transplant
  • Any patient who utilizes telehealth services